Results 111 to 120 of about 351 (170)

Next-Generation HER2-Targeted Antibody-Drug Conjugates in Breast Cancer. [PDF]

Cancers (Basel)
Zimmerman BS, Esteva FJ.
europepmc   +1 more source

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future. [PDF]

Front Pharmacol
Xu L, Xie Y, Gou Q, Cai R, Bao R, Huang Y, Tang R.   +6 more
europepmc   +1 more source

Barok

, 2005
openaire   +1 more source

Trastuzumab emtansine: mechanisms of action and drug resistance. [PDF]

Breast Cancer Res, 2014
Barok M, Joensuu H, Isola J.
europepmc   +1 more source

Surface-Available HER2 Levels Alone Are Not Indicative of Cell Response to HER2-Targeted Antibody-Drug Conjugate Therapies. [PDF]

Pharmaceutics
Major M, Nervig CS, Gerland A, Owen SC.
europepmc   +1 more source

Nature's carriers: leveraging extracellular vesicles for targeted drug delivery. [PDF]

Drug Deliv
Chen Q, Zheng Y, Jiang X, Wang Y, Chen Z, Wu D.   +5 more
europepmc   +1 more source

Production of hydroxycinnamoyl-shikimates and chlorogenic acid in Escherichia coli: production of hydroxycinnamic acid conjugates. [PDF]

Microb Cell Fact, 2013
Kim BG, Jung WD, Mok H, Ahn JH.
europepmc   +1 more source

Low level CO₂ supplementation maintains isocapnia and reveals ventilatory long-term facilitation in rats. [PDF]

Respir Physiol Neurobiol
Miller S, Lopez EJ, Grittner JML, Dougherty BJ.   +3 more
europepmc   +1 more source

Efficacy and safety of antibody-drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials. [PDF]

Front Pharmacol
Ren JW, Chen ZY, Bai YJ, Han P.
europepmc   +1 more source

Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer. [PDF]

Open Life Sci
Zhao J, Shen F, Hu YM, Yin K, Chen Y, Chen YJ, Hu QC, Liang L.   +7 more
europepmc   +1 more source